379 related articles for article (PubMed ID: 31173217)
1. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
3. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
4. Cell division cycle associated 7 like predicts unfavorable prognosis and promotes invasion in glioma.
Shen FZ; Li XS; Ma JW; Wang XY; Zhao SP; Meng L; Liang SF; Zhao XL
Pathol Res Pract; 2019 Jan; 215(1):50-56. PubMed ID: 30389317
[TBL] [Abstract][Full Text] [Related]
5. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma.
Mao H; Nian J; Wang Z; Li X; Huang C
Pathol Res Pract; 2020 Jul; 216(7):152996. PubMed ID: 32534703
[TBL] [Abstract][Full Text] [Related]
6. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.
Zhao L; Tang X; Luo R; Duan J; Wang Y; Yang B
Curr Neurovasc Res; 2018; 15(3):246-255. PubMed ID: 30101705
[TBL] [Abstract][Full Text] [Related]
9. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
[No Abstract] [Full Text] [Related]
10. miR-491 regulates glioma cells proliferation by targeting TRIM28 in vitro.
Qi Z; Cai S; Cai J; Chen L; Yao Y; Chen L; Mao Y
BMC Neurol; 2016 Dec; 16(1):248. PubMed ID: 27905892
[TBL] [Abstract][Full Text] [Related]
11. CDCA7L promotes hepatocellular carcinoma progression by regulating the cell cycle.
Tian Y; Huang C; Zhang H; Ni Q; Han S; Wang D; Han Z; Li X
Int J Oncol; 2013 Dec; 43(6):2082-90. PubMed ID: 24141559
[TBL] [Abstract][Full Text] [Related]
12. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
Zhao W; Sun C; Cui Z
Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
[TBL] [Abstract][Full Text] [Related]
14. FAM84B promotes the proliferation of glioma cells through the cell cycle pathways.
Ren D; Zhuang X; Lv Y; Zhang Y; Xu J; Gao F; Chen D; Wang Y
World J Surg Oncol; 2022 Nov; 20(1):368. PubMed ID: 36419094
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-519d-3p inhibits cell proliferation and cell cycle G1/S transition in glioma by targeting CCND1.
Ma L; Li J
Biosci Biotechnol Biochem; 2020 Feb; 84(2):297-304. PubMed ID: 31661371
[TBL] [Abstract][Full Text] [Related]
16. FOXO4 expression associates with glioblastoma development and FOXO4 expression inhibits cell malignant phenotypes in vitro and in vivo.
Qi M; Sun LA; Jiang XC; Han YL; Wang L; Niu WH; Fei MX; Zhaba WD; Zheng LR; Zhou ML
Life Sci; 2020 Apr; 247():117436. PubMed ID: 32070707
[TBL] [Abstract][Full Text] [Related]
17. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
18. Interference with PSMB4 Expression Exerts an Anti-Tumor Effect by Decreasing the Invasion and Proliferation of Human Glioblastoma Cells.
Cheng YC; Tsai WC; Sung YC; Chang HH; Chen Y
Cell Physiol Biochem; 2018; 45(2):819-831. PubMed ID: 29414809
[TBL] [Abstract][Full Text] [Related]
19. GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.
Zhang S; Gao M; Yu L
Cancer Med; 2019 Sep; 8(11):5242-5253. PubMed ID: 31286678
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
